Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 17/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.41 |
| ▸ | ITGAV | P06756 | 4/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7403042 | 0.90 | ITGB3 (0.42) | ITGB3ITGA2BSMPD1ITGAVCHRM2 | |
| SCHEMBL7403041 | 0.88 | ITGB3 (0.42) | ITGB3ITGA2BSMPD1ITGAVCHRM2 | |
| SCHEMBL7979125 | 0.85 | ITGB3 (0.46) | ITGB3ITGA2BITGAV | |
| SCHEMBL7982063 | 0.85 | ITGB3 (0.42) | ITGB3ITGA2BSMPD1 | |
| SCHEMBL7399998 | 0.84 | ITGB3 (0.51) | ITGB3ITGA2BITGAV | |
| SCHEMBL7399991 | 0.81 | ITGB3 (0.38) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL6111432 | 0.78 | ITGB3 (0.46) | ITGB3ITGA2BITGAV | |
| SCHEMBL7407939 | 0.76 | SMPD1 (0.42) | ITGB3ITGA2BSMPD1ITGAV | |
| SCHEMBL7969118 | 0.75 | ITGB3 (0.44) | ITGB3ITGA2BITGAV | |
| SCHEMBL7985930 | 0.75 | ITGB3 (0.42) | ITGB3ITGA2BITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6214834-B1 | ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS | DUPONT PHARMACEUTICALS COMPANY | 2001-04-10 | — | — | US | disclosed |